brands of glp-1 drugs How medications are transforming diabetes and weight loss treatment GLP-1 Drugs and The Pharma
Description
Accessed February 23, 2026.
Among children ages 2 to 19, obesity rates climbed from 18% to 26%, and they rose from 30% to 38% among adults 20 and older
France holds a 17.1% share in 2025, expected to maintain 16.9% by 2035, supported by healthcare system demand and pharmaceutical applications, but facing challenges from market competition and healthcare budget considerations
Urinary tract infections
Diabetes 15 (2), 287304
Manufacturing capacity has emerged as an equally important competitive moat
